Flourish Research Acquires Center for Advanced Research & Education (CARE)

Flourish Research Acquires Diablo Clinical Research

February 18, 2025

Healthcare Services

Flourish Research, a multi-site clinical trial organization headquartered in Apex, North Carolina, has acquired Diablo Clinical Research, a Walnut Creek, California-based clinical research facility established in 1995 that has conducted more than 1,000 phase I–IV trials and medical device studies. The add-on acquisition (Flourish is PE-backed by Genstar Capital) expands Flourish's geographic footprint and therapeutic-area capabilities, particularly in endocrinology, cardiovascular and metabolic research.

Genstar Capital Acquires Majority Stake in Flourish Research

September 18, 2024

Healthcare Services

Genstar Capital has made a strategic majority investment in Flourish Research, a multi-site clinical trial organization headquartered in Apex, North Carolina. The transaction represents an exit for NMS Capital, which built Flourish into a 24-site network with ~150 investigators and scaled the business through infrastructure investments and acquisitions.

Flourish Research (NMS Capital) Recapitalizes AMC Research and Central Research Associates

May 18, 2023

Healthcare Services

NMS Capital portfolio company Flourish Research partnered with company management to recapitalize AMC Research, LLC (Charlotte, NC) and Central Research Associates (Birmingham, AL). The transactions expand Flourish’s clinical research site network—augmenting its Alzheimer’s capabilities and adding scale in cardiology/metabolic/renal, vaccine and other therapeutic areas; terms were not disclosed.

CenExel Acquires ForCare Clinical Research

August 4, 2021

Healthcare Services

CenExel Clinical Research has acquired Tampa-based ForCare Clinical Research, adding a dermatology- and immunology-focused clinical research site to its Centers of Excellence network. The addition strengthens CenExel's capabilities to conduct Phase I–IV trials across dermatology, immunology and other therapeutic areas and will integrate ForCare into CenExel's centralized operations and quality systems. Provident Healthcare Partners served as exclusive sell-side financial advisor to ForCare in the transaction.

Flourish Research Acquires ENCORE Research Group

June 25, 2024

Healthcare Services

NMS Capital portfolio company Flourish Research has partnered with ENCORE Research Group, a clinical research organization with eight locations across Northern Florida and more than 100 investigators. The transaction — the eleventh add-on to the Flourish platform since 2021 — expands Flourish's geographic footprint and therapeutic capabilities; terms were not disclosed.

Flourish Research (NMS Capital-backed) Acquires Valley Clinical Trials

September 15, 2023

Healthcare Services

NMS Capital–backed Flourish Research has acquired Valley Clinical Trials, a three-site clinical research organization in Los Angeles County focused on cardiology, metabolic and related therapeutic areas. The deal — Flourish’s ninth acquisition since 2021 — expands the platform’s West Coast footprint; terms were not disclosed and Valley’s founder and management will remain in their roles.